World J Mens Health.  2017 Aug;35(2):59-64. 10.5534/wjmh.2017.35.2.59.

Hypertension and Male Fertility

• Guo D
• Li S
• Behr B
• Eisenberg

• KMID: 2388441
• DOI: http://doi.org/10.5534/wjmh.2017.35.2.59

Abstract

As the age of paternity rises in the developed world, issues of chronic disease may affect prospective fathers. Given the high prevalence of hypertension, researchers have begun to explore the relationship between hypertensive disease and male fertility. The current literature suggests an association between hypertension and semen quality. The use of various antihypertensive medications has also been linked to impaired semen parameters, making it difficult to discern whether the association exists with hypertension or its treatment. Further investigation is warranted to determine whether the observed associations are causal.

Keyword

Adrenergic beta-antagonists; Hypertension; Infertility; Semen analysis

MeSH Terms

Adrenergic beta-Antagonists
Chronic Disease
Fathers
Fertility*
Humans
Hypertension*
Infertility
Male*
Paternity
Prevalence
Prospective Studies
Semen
Semen Analysis
Adrenergic beta-Antagonists

Reference

1. Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015; 64:1–65.

2. Eisenberg ML, Li S, Behr B, Pera RR, Cullen MR. Relationship between semen production and medical comorbidity. Fertil Steril. 2015; 103:66–71. PMID: 25497466.

3. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013; (133):1–8.

4. Aitken M. Medicines use and spending shifts: a review of the use of medicines in the U.S. in 2014. Parsippany (NJ): IMS Institute for Health Informatics;2015.

5. Bener A, Al-Ansari AA, Zirie M, Al-Hamaq AO. Is male fertility associated with type 2 diabetes mellitus? Int Urol Nephrol. 2009; 41:777–784. PMID: 19381857.

6. Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, Buck Louis GM. The relationship between male BMI and waist circumference on semen quality: data from the LIFE study. Hum Reprod. 2014; 29:193–200. PMID: 24306102.

7. Schisterman EF, Mumford SL, Chen Z, Browne RW, Boyd Barr D, Kim S, et al. Lipid concentrations and semen quality: the LIFE study. Andrology. 2014; 2:408–415. PMID: 24596332.

8. Sermondade N, Faure C, Fezeu L, Shayeb AG, Bonde JP, Jensen TK, et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update. 2013; 19:221–231. PMID: 23242914.

9. Ventimiglia E, Capogrosso P, Boeri L, Serino A, Colicchia M, Ippolito S, et al. Infertility as a proxy of general male health: results of a cross-sectional survey. Fertil Steril. 2015; 104:48–55. PMID: 26006735.

10. Breigeiron MK, Lucion AB, Sanvitto GL. Effects of renovascular hypertension on reproductive function in male rats. Life Sci. 2007; 80:1627–1634. PMID: 17316702.

11. Muciaccia B, Pensini S, Culasso F, Padula F, Paoli D, Gandini L, et al. Higher clusterin immunolabeling and sperm DNA damage levels in hypertensive men compared with controls. Hum Reprod. 2012; 27:2267–2276. PMID: 22647452.

12. Coetzee K, Kruger TF, Lombard CJ. Repeatability and variance analysis on multiple computer-assisted (IVOS) sperm morphology readings. Andrologia. 1999; 31:163–168. PMID: 10363121.

13. Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril. 1988; 49:112–117. PMID: 3335257.

14. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010; 16:231–245. PMID: 19934213.

15. Guo D, Li S, Behr B, Eisenberg M. PD52-12 The impact of hypertension and antihypertensives on semen quality. J Urol. 2015; 193:e1117.

16. Eisenberg ML, Li S, Behr B, Cullen MR, Galusha D, Lamb DJ, et al. Semen quality, infertility and mortality in the USA. Hum Reprod. 2014; 29:1567–1574. PMID: 24838701.

17. Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol. 2009; 170:559–565. PMID: 19635736.

18. Eisenberg ML, Li S, Brooks JD, Cullen MR, Baker LC. Increased risk of cancer in infertile men: analysis of U.S. claims data. J Urol. 2015; 193:1596–1601. PMID: 25463997.

19. Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ. 2000; 321:789–792. PMID: 11009515.

20. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009; 169:351–356. PMID: 19237718.

21. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, et al. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010; 116:2140–2147. PMID: 20309846.

22. Eisenberg ML, Li S, Cullen MR, Baker LC. Increased risk of incident chronic medical conditions in infertile men: analysis of United States claims data. Fertil Steril. 2016; 105:629–636. PMID: 26674559.

23. Svartberg J, von Mühlen D, Schirmer H, Barrett-Connor E, Sundfjord J, Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol. 2004; 150:65–71. PMID: 14713281.

24. Fogari R, Zoppi A, Preti P, Rinaldi A, Marasi G, Vanasia A, et al. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens. 2002; 15:217–221. PMID: 11939610.

25. Salonia A, Matloob R, Gallina A, Abdollah F, Saccà A, Briganti A, et al. Are infertile men less healthy than fertile men? Results of a prospective case-control survey. Eur Urol. 2009; 56:1025–1031. PMID: 19297076.

26. Barker DJ. Fetal origins of coronary heart disease. BMJ. 1995; 311:171–174. PMID: 7613432.

27. Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, Toppari J, Andersson AM, Eisenberg ML, et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol Rev. 2016; 96:55–97. PMID: 26582516.

28. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001; 16:972–978. PMID: 11331648.

29. Samplaski MK, Nangia AK. Adverse effects of common medications on male fertility. Nat Rev Urol. 2015; 12:401–413. PMID: 26101108.

30. Homonnai ZT, Shilon M, Paz GF. Phenoxybenzamine: an effective male contraceptive pill. Contraception. 1984; 29:479–491. PMID: 6430643.

31. Hershlag A, Cooper GW, Benoff S. Pregnancy following discontinuation of a calcium channel blocker in the male partner. Hum Reprod. 1995; 10:599–606. PMID: 7782439.

32. Benoff S, Cooper GW, Hurley I, Mandel FS, Rosenfeld DL, Scholl GM, et al. The effect of calcium ion channel blockers on sperm fertilization potential. Fertil Steril. 1994; 62:606–617. PMID: 8062958.

33. Mbah AU, Ndukwu GO, Ghasi SI, Shu EN, Ozoemena FN, Mbah JO, et al. Low-dose lisinopril in normotensive men with idiopathic oligospermia and infertility: a 5-year randomized, controlled, crossover pilot study. Clin Pharmacol Ther. 2012; 91:582–589. PMID: 22378155.